Skip to main content

Table 4 Antimicrobial susceptibility of Gram-positive isolates

From: Epidemiology of patients with central nervous system infections, mainly neurosurgical patients: a retrospective study from 2012 to 2019 in a teaching hospital in China

  CoNS (N = 37) Streptococcus pneumoniae (N = 5) Enterococcus faecium (N = 5)
  n S I R n S I R n S I R
Penicillin 37 1 (2.7%)   36 (97.3%) 5 2 (40%)   3 (60%) 5    5 (100%)
Oxacillin 37 7 (18.9%)   30 (81.1%)       
Ampicillin        5    5 (100%)
Amoxicillin-Clavulanate 34 7 (20.6%)   27 (79.4%)       
Cefazolin 28 4 (14.3%)   24 (85.7%)       
Ciprofloxacin 16 5 (31.3%)   11 (68.8%)     5    5 (100%)
Levofloxacin 20 8 (40%) 5 (25%) 7 (35%) 5 5 (100%)      
Moxifloxacin 6 3 (50%) 1(16.7%) 2(33.3%) 5 5 (100%)      
Tetracycline 36 27 (75%)   9 (25%) 5   1 (20%) 4 (80%) 5 3 (60%)   2 (40%)
Erythrocin 37 4 (10.8%)   33 (89.2%) 5   1 (20%) 4 (80%)    
Clindamycin 37 14 (37.8%) 7 (18.9%) 16 (43.2%) 3    3 (100%)    
Chloramphenicol     5 4 (80%)   1 (20%) 5 3 (60%) 2 (40%)  
Rifampicin 35 28 (80%)   7 (20%) 2 2 (100%)    5 1 (20%)   4 (80%)
Compound Sulfamethoxazole 37 9 (24.3%)   28 (75.7%) 5 2 (40%) 1 (20%) 2 (40%)    
Gentamicin 37 21 (56.8%) 1 (2.7%) 15 (40.5%)     5 1 (20%)   4 (80%)
Vancomycin 37 37 (100%)    5 5 (100%)    5 5 (100%)   
Teicoplanin 37 37 (100%)    5 5 (100%)    5 5 (100%)   
Linezolid 37 37 (100%)    2 2 (100%)    5 5 (100%)   
  1. S sensitive, I intermediary, R resistant, (–) not done